| 000 | 01428 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515092518.0 | ||
| 264 | 0 | _c20080515 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a0167-0115 | ||
| 024 | 7 |
_a10.1016/j.regpep.2007.08.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrabowska, A M | |
| 245 | 0 | 0 |
_aPre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models. _h[electronic resource] |
| 260 |
_bRegulatory peptides _cFeb 2008 |
||
| 300 |
_a46-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 |
_aBenzodiazepinones _xchemistry |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aGastrointestinal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aReceptor, Cholecystokinin B _xantagonists & inhibitors |
| 700 | 1 | _aMorris, T M | |
| 700 | 1 | _aMcKenzie, A J | |
| 700 | 1 | _aKumari, R | |
| 700 | 1 | _aHamano, H | |
| 700 | 1 | _aEmori, Y | |
| 700 | 1 | _aYoshinaga, K | |
| 700 | 1 | _aWatson, S A | |
| 773 | 0 |
_tRegulatory peptides _gvol. 146 _gno. 1-3 _gp. 46-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.regpep.2007.08.007 _zAvailable from publisher's website |
| 999 |
_c17481013 _d17481013 |
||